18F-fluorodeoxyglucose–positron emission tomography/computed tomography for the diagnosis of polymyalgia-like illnesses: a retrospective study

Abstract Background Various inflammatory conditions may present with musculoskeletal symptoms similar to those of polymyalgia rheumatica (PMR). We investigated findings on 18F-fluorodexoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) images that may differentiate PMR from p...

Full description

Bibliographic Details
Main Authors: Hideyuki Horikoshi, Takashi Nakanishi, Katsumi Tamura, Fumihiko Kimura, Kenji Itoh
Format: Article
Language:English
Published: BMC 2020-04-01
Series:BMC Rheumatology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s41927-020-00121-y
id doaj-1f999b8023d148bc82cf68749686c066
record_format Article
spelling doaj-1f999b8023d148bc82cf68749686c0662020-11-25T02:34:37ZengBMCBMC Rheumatology2520-10262020-04-01411610.1186/s41927-020-00121-y18F-fluorodeoxyglucose–positron emission tomography/computed tomography for the diagnosis of polymyalgia-like illnesses: a retrospective studyHideyuki Horikoshi0Takashi Nakanishi1Katsumi Tamura2Fumihiko Kimura3Kenji Itoh4Division of Hematology and Rheumatology, Department of Internal Medicine, National Defense Medical CollegeDivision of Hematology and Rheumatology, Department of Internal Medicine, National Defense Medical CollegeTokorozawa PET Diagnostic Imaging ClinicDivision of Hematology and Rheumatology, Department of Internal Medicine, National Defense Medical CollegeDivision of Hematology and Rheumatology, Department of Internal Medicine, National Defense Medical CollegeAbstract Background Various inflammatory conditions may present with musculoskeletal symptoms similar to those of polymyalgia rheumatica (PMR). We investigated findings on 18F-fluorodexoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) images that may differentiate PMR from polymyalgia-like illnesses. Methods We analyzed data from 25 patients with new-onset polymyalgia-like illnesses who fulfilled Bird’s diagnostic criteria for PMR and had undergone FDG–PET/CT scan. To assess the uptake by major joints and synovial bursae, particularly at PMR-specific sites (shoulder, sternoclavicular, and hip joints, interspinous bursae, ischial tuberosities, and greater trochanters), we used visual scoring system to score FDG uptake: 0, no uptake (same as bone); 1, slight uptake; 2, moderate uptake (same as the liver); 3, greater uptake than the liver; and 4, uptake as strong as in the cerebellum. Results The final diagnoses were PMR in 17 patients and non-PMR in eight patients (three malignancies, two infections, one cholesterol crystal embolism, one ANCA-associated vasculitis, and one undefined diagnosis). Although the serum MMP-3 levels were significantly higher in patients with PMR, C-reactive protein and erythrocyte sedimentation rate mean values did not differ between the two groups. In PMR-specific sites, FDG accumulations were observed in all cases of PMR, with a high PET-positive score of 2.00 (range, 0–3), but it was low in non-PMR cases, with a PET-positive score of 1.00 (range, 0–3). Conclusions The FDG accumulation patterns in polymyalgia-like illness differ from those in PMR, despite the similar clinical presentations of both conditions. An FDG–PET/CT scan is useful for differentiating PMR from other polymyalgia-like illnesses.http://link.springer.com/article/10.1186/s41927-020-00121-yPolymyalgia-like illnessPolymyalgia rheumaticaFDG–PET/CT
collection DOAJ
language English
format Article
sources DOAJ
author Hideyuki Horikoshi
Takashi Nakanishi
Katsumi Tamura
Fumihiko Kimura
Kenji Itoh
spellingShingle Hideyuki Horikoshi
Takashi Nakanishi
Katsumi Tamura
Fumihiko Kimura
Kenji Itoh
18F-fluorodeoxyglucose–positron emission tomography/computed tomography for the diagnosis of polymyalgia-like illnesses: a retrospective study
BMC Rheumatology
Polymyalgia-like illness
Polymyalgia rheumatica
FDG–PET/CT
author_facet Hideyuki Horikoshi
Takashi Nakanishi
Katsumi Tamura
Fumihiko Kimura
Kenji Itoh
author_sort Hideyuki Horikoshi
title 18F-fluorodeoxyglucose–positron emission tomography/computed tomography for the diagnosis of polymyalgia-like illnesses: a retrospective study
title_short 18F-fluorodeoxyglucose–positron emission tomography/computed tomography for the diagnosis of polymyalgia-like illnesses: a retrospective study
title_full 18F-fluorodeoxyglucose–positron emission tomography/computed tomography for the diagnosis of polymyalgia-like illnesses: a retrospective study
title_fullStr 18F-fluorodeoxyglucose–positron emission tomography/computed tomography for the diagnosis of polymyalgia-like illnesses: a retrospective study
title_full_unstemmed 18F-fluorodeoxyglucose–positron emission tomography/computed tomography for the diagnosis of polymyalgia-like illnesses: a retrospective study
title_sort 18f-fluorodeoxyglucose–positron emission tomography/computed tomography for the diagnosis of polymyalgia-like illnesses: a retrospective study
publisher BMC
series BMC Rheumatology
issn 2520-1026
publishDate 2020-04-01
description Abstract Background Various inflammatory conditions may present with musculoskeletal symptoms similar to those of polymyalgia rheumatica (PMR). We investigated findings on 18F-fluorodexoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) images that may differentiate PMR from polymyalgia-like illnesses. Methods We analyzed data from 25 patients with new-onset polymyalgia-like illnesses who fulfilled Bird’s diagnostic criteria for PMR and had undergone FDG–PET/CT scan. To assess the uptake by major joints and synovial bursae, particularly at PMR-specific sites (shoulder, sternoclavicular, and hip joints, interspinous bursae, ischial tuberosities, and greater trochanters), we used visual scoring system to score FDG uptake: 0, no uptake (same as bone); 1, slight uptake; 2, moderate uptake (same as the liver); 3, greater uptake than the liver; and 4, uptake as strong as in the cerebellum. Results The final diagnoses were PMR in 17 patients and non-PMR in eight patients (three malignancies, two infections, one cholesterol crystal embolism, one ANCA-associated vasculitis, and one undefined diagnosis). Although the serum MMP-3 levels were significantly higher in patients with PMR, C-reactive protein and erythrocyte sedimentation rate mean values did not differ between the two groups. In PMR-specific sites, FDG accumulations were observed in all cases of PMR, with a high PET-positive score of 2.00 (range, 0–3), but it was low in non-PMR cases, with a PET-positive score of 1.00 (range, 0–3). Conclusions The FDG accumulation patterns in polymyalgia-like illness differ from those in PMR, despite the similar clinical presentations of both conditions. An FDG–PET/CT scan is useful for differentiating PMR from other polymyalgia-like illnesses.
topic Polymyalgia-like illness
Polymyalgia rheumatica
FDG–PET/CT
url http://link.springer.com/article/10.1186/s41927-020-00121-y
work_keys_str_mv AT hideyukihorikoshi 18ffluorodeoxyglucosepositronemissiontomographycomputedtomographyforthediagnosisofpolymyalgialikeillnessesaretrospectivestudy
AT takashinakanishi 18ffluorodeoxyglucosepositronemissiontomographycomputedtomographyforthediagnosisofpolymyalgialikeillnessesaretrospectivestudy
AT katsumitamura 18ffluorodeoxyglucosepositronemissiontomographycomputedtomographyforthediagnosisofpolymyalgialikeillnessesaretrospectivestudy
AT fumihikokimura 18ffluorodeoxyglucosepositronemissiontomographycomputedtomographyforthediagnosisofpolymyalgialikeillnessesaretrospectivestudy
AT kenjiitoh 18ffluorodeoxyglucosepositronemissiontomographycomputedtomographyforthediagnosisofpolymyalgialikeillnessesaretrospectivestudy
_version_ 1724807897959890944